PTPN11 mutations are not responsible for the Cardiofaciocutaneous (CFC) syndrome

Cardiofaciocutaneous (CFC) syndrome is a multiple congenital anomalies/mental retardation syndrome characterized by congenital heart defects, characteristic facial appearance, short stature, ectodermal abnormalities and mental retardation. It was described in 1986, and to date is of unknown genetic etiology. All reported cases are sporadic, born to non-consanguineous parents and have apparently normal chromosomes. Noonan and Costello syndromes remain its main differential diagnosis. The recent finding of PTPN11 missense mutations in 45–50% of the Noonan patients studied with penetrance of almost 100% and the fact that in animals mutations of this gene cause defects of semilunar valvulogenesis, made PTPN11 mutation screening in CFC patients a matter of interest. We sequenced the entire coding region of the PTPN11 gene in ten well-characterised CFC patients and found no base changes. We also studied PTPN11 cDNA in our patients and demonstrated that there are no interstitial deletions either. The genetic cause of CFC syndrome remains unknown, and PTPN11 can be reasonably excluded as a candidate gene for the CFC syndrome, which we regard as molecular evidence that CFC and Noonan syndromes are distinct genetic entities.

[1]  M. Digilio,et al.  Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. , 2002, American journal of human genetics.

[2]  T. Magnuson,et al.  Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis , 2000, Nature Genetics.

[3]  J. Fryns,et al.  Retinitis pigmentosa in a young man with Noonan syndrome: further evidence that Noonan syndrome (NS) and the cardio-facio-cutaneous syndrome (CFC) are variable manifestations of the same entity? , 1996, American journal of medical genetics.

[4]  T. Ogata,et al.  Noonan syndrome: genotype analysis of the Noonan syndrome critical region at chromosome 12q in a three-generation family. , 1998, American journal of medical genetics.

[5]  Bruce D Gelb,et al.  PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. , 2002, American journal of human genetics.

[6]  Paul Steinbok,et al.  Editorial Comment , 2000, Child's Nervous System.

[7]  J. Fryns,et al.  Fine mapping of Noonan/cardio-facio cutaneous syndrome in a large family , 1998, European Journal of Human Genetics.

[8]  S. Shoelson,et al.  Crystal Structure of the Tyrosine Phosphatase SHP-2 , 1998, Cell.

[9]  J. Opitz,et al.  New multiple congenital anomalies/mental retardation syndrome with cardio-facio-cutaneous involvement--the CFC syndrome. , 1986, American journal of medical genetics.

[10]  A. Fryer,et al.  The cardio-facio-cutaneous (CFC) syndrome and Noonan syndrome: are they the same? , 1991, American journal of medical genetics.

[11]  E. Mariman,et al.  Mapping a gene for Noonan syndrome to the long arm of chromosome 12 , 1994, Nature Genetics.

[12]  M. Zollino,et al.  The Noonan-CFC controversy. , 1991, American journal of medical genetics.

[13]  T. Grebe,et al.  Neurologic and gastrointestinal dysfunction in cardio-facio-cutaneous syndrome: identification of a severe phenotype. , 2000, American journal of medical genetics.

[14]  D. Brunoni,et al.  CFC index for the diagnosis of cardiofaciocutaneous syndrome. , 2002, American journal of medical genetics.

[15]  J. Fryns,et al.  Mutation in the gene for protein tyrosine phosphatase SHP-2 (PTPN11) in a large family with Noonan/cardio-facio-cutaneous syndrome , 2002 .

[16]  Michael A. Patton,et al.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome , 2001, Nature Genetics.